Simultaneous determination of six tumor markers in patients with prostatic carcinoma and bladder tumors
- 1 June 1985
- journal article
- research article
- Published by Springer Nature in Urological Research
- Vol. 13 (3) , 133-136
- https://doi.org/10.1007/bf00256074
Abstract
Summary Serum levels of fucosyltransferase (FT), phosphohexoseisomerase (PHI), tissue polypeptide antigen (TPA), Tennessee antigen (TAG), carcinoembryonic antigen (CEA) and prostatic acid phosphate (PAP) were determined in 75 healthy individuals and in 86 patients with prostatic carcinoma and 38 patients with bladder tumors. The discrimination capacities of the different markers were compared by using inverse distribution plots. At a rate of 5% false positive values the sensitivities for bladder tumors were: FT 30%, TPA 24%, CEA 16%, TAG 15%. The sensitivities for prostatic carcinoma were: PAP 63%, PHI 36%, TPA 18%, CEA 14%, TAG 14%.Keywords
This publication has 8 references indexed in Scilit:
- Significance of plasma tissue polypeptide antigen determination for diagnosis and follow-up of urothelial bladder cancerUrological Research, 1984
- The Tennessee antigen test. An evaluation in cancer and non-cancer patients and normal subjectsBritish Journal of Cancer, 1982
- Levels of Two Plasma Fucosyltransferases as an Index of Disease Status in Patients with Acute Myelogenous LeukemiaPublished by Elsevier ,1979
- Fucosyltransferase Activity in Metastasizing and Nonmetastasizing Rat Mammary Carcinomas2JNCI Journal of the National Cancer Institute, 1978
- Selective inhibition of a plasma fucosyltransferase by N-ethylmaleimideBiochemical and Biophysical Research Communications, 1977
- GLYCOSYLTRANSFERASES AND GLYCOSIDASES IN MORRIS HEPATOMAS1977
- Evaluation of Biological Markers in Bladder CancerJournal of Urology, 1975
- Serum phosphohexose isomerase in cancer.II. As an index of tumor growth in metastatic carcinoma of the breastCancer, 1954